We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLBC icon
2626
Plumas Bancorp
PLBC
$442M
$83K ﹤0.01%
3,737
+3,465
+1,274% +$67.2K
SCPH
2627
DELISTED
scPharmaceuticals
SCPH
$83K ﹤0.01%
11,240
+9,639
+602% +$84.7K
SHOP icon
2628
Shopify
SHOP
$204B
$83K ﹤0.01%
870
-35,920
-98% -$2.49M
TK icon
2629
Teekay
TK
$1.06B
$83K ﹤0.01%
+34,613
New +$106K
COWN
2630
DELISTED
Cowen Inc. Class A Common Stock
COWN
$83K ﹤0.01%
+5,118
New +$62.1K
ACRE
2631
Ares Commercial Real Estate
ACRE
$264M
$82K ﹤0.01%
9,016
-6,669
-43% -$52K
ALK icon
2632
Alaska Air
ALK
$5.3B
$82K ﹤0.01%
2,244
-16,556
-88% -$539K
ANDE icon
2633
Andersons Inc
ANDE
$2.21B
$82K ﹤0.01%
+5,994
New +$87K
FLIC
2634
DELISTED
First of Long Island Corp
FLIC
$82K ﹤0.01%
+5,043
New +$77.3K
HMC icon
2635
Honda
HMC
$40.5B
$82K ﹤0.01%
+3,191
New +$77.5K
LAB icon
2636
Standard BioTools
LAB
$294M
$82K ﹤0.01%
+20,444
New +$71.2K
MX icon
2637
Magnachip Semiconductor
MX
$137M
$82K ﹤0.01%
7,956
+3,282
+70% +$36.6K
SFIX
2638
Stitch Fix
SFIX
$487M
$82K ﹤0.01%
3,308
+2,964
+862% +$58.5K
SPB icon
2639
Spectrum Brands
SPB
$2.09B
$82K ﹤0.01%
1,797
+1,523
+556% +$64.7K
ARAV
2640
DELISTED
Aravive, Inc. Common Stock
ARAV
$82K ﹤0.01%
7,043
+6,103
+649% +$72.4K
FORR icon
2641
Forrester Research
FORR
$224M
$81K ﹤0.01%
+2,527
New +$80.2K
FSFG
2642
DELISTED
First Savings Financial Group
FSFG
$81K ﹤0.01%
5,640
+3,822
+210% +$54.5K
NGVC icon
2643
Vitamin Cottage Natural Grocers
NGVC
$646M
$81K ﹤0.01%
+5,506
New +$67K
OCUL icon
2644
Ocular Therapeutix
OCUL
$2.22B
$81K ﹤0.01%
9,674
+7,582
+362% +$50.3K
OFIX icon
2645
Orthofix Medical
OFIX
$415M
$81K ﹤0.01%
+2,512
New +$83.4K
FFG
2646
DELISTED
FBL Financial Group
FFG
$81K ﹤0.01%
+2,249
New +$82.7K
MTSC
2647
DELISTED
MTS Systems Corp
MTSC
$81K ﹤0.01%
+4,599
New +$85K
RRBI icon
2648
Red River Bancshares
RRBI
$681M
$80K ﹤0.01%
1,824
+1,115
+157% +$43.5K
CNR
2649
Core Natural Resources Inc
CNR
$4.64B
$80K ﹤0.01%
15,755
+7,240
+85% +$45.1K
BCEL
2650
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$80K ﹤0.01%
+3,749
New +$66.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.